Ever Supreme Bio Technology Co., Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 758.39 million compared to TWD 627.51 million a year ago. Net income was TWD 539.4 million compared to TWD 200.71 million a year ago.

Basic earnings per share from continuing operations was TWD 7.24 compared to TWD 2.68 a year ago. Diluted earnings per share from continuing operations was TWD 7.22 compared to TWD 2.66 a year ago.